Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Regenerative medicine is area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair. Regenerative Medicine is a branch of translational research in Tissue Engineering and Molecular Biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. Regenerative medicine is a very broad, new approach to medicine which uses the advances in stem cell technology, primarily, to advance clinical care. And what that really converts into is that instead of treating chronic diseases with drugs that have a short-term effect, and that need to be continued long term as a consequence, we can think in terms of regenerative medicine of solutions to problems.
The main aim of the regenerative medicine is to engineer damaged tissues and organs via stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs. This field holds the promise of engineering damaged tissues and organs via stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.
Regenerative Medicine conference is a platform to explore the dynamic, rapidly-changing research and breakthroughs impacting our target areas in regenerative medicine. Regenerative Medicine conference is designed to raise awareness about the present opportunities in developing and existing therapies already in translation. Regenerative Medicine Conference provide a wide range of learning opportunities progressed by international and national experts. Regenerative Medicine Conference offers an opportunity to foster dialogue and exchange of knowledge between leading researchers, physicians, philanthropists, investors and policy makers.
Scope & Importance
Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies. This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents, and tissue chips that can be used to test the toxicity of an experimental medication. Tissue Engineering and Regenerative Medicine is the major field in Medicine, which is still under research and the advancements are maximizing day to day.
There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.
OMICS International organises 1000+ Global Events every year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
This page will be updated regularly.
This page was last updated on January 18, 2020